MindWalk Q1 FY2027: Revenue Up 21%, Gross Margin Hits 59%, $30M Credit Facility Secured
HYFT sits 31% above its 52-week low of $0.99.
Summary
MindWalk reported Q1 FY2027 revenue of C$3.8 million (up 21.3%) with gross margin expanding to 58.6%, and announced a US$30 million non-dilutive credit facility from Sanabil (Cayman) at 7.00% with no warrants or covenants.
Key Events · Earnings and Guidance · HYFT
-
Q1 FY2027 Revenue Up 21.3%
Revenue reached C$3.8 million, up from C$3.2 million in the prior-year quarter, with gross profit rising 47.1% to C$2.2 million.
-
Gross Margin Expands to 58.6%
Gross margin improved 10.3 percentage points from 48.3% to 58.6%, as cost of sales held flat at C$1.6 million while revenue grew.
-
US$30M Non-Dilutive Credit Facility
Binding commitment from Sanabil (Cayman) for a senior unsecured revolving credit facility at fixed 7.00% interest, with no financial maintenance covenants, no warrants or conversion feature, and no asset pledge. Target closing within 60 days.
-
Cash Position Declines to C$7.6M
Cash fell from C$11.3 million at April 30, 2026 to C$7.6 million at July 31, 2026, before the credit facility commitment. Net cash used in operating activities was C$4.0 million.
Analysis · HYFT · Life Sciences
A strong quarter for MindWalk, with revenue up 21.3% to C$3.8 million and gross margin expanding to 58.6% from 48.3%, was paired with a US$30 million unsecured revolving credit facility at a fixed 7.00% rate—no warrants, no conversion feature, no asset pledge. The credit facility is particularly significant given the company's going concern warning disclosed in its July 20-F and its declining cash position (C$7.6 million at quarter-end, down from C$11.3 million three months earlier). It provides non-dilutive runway to fund the ReefIQ enterprise rollout without issuing shares, addressing the company's most pressing risk. The larger net loss (C$6.1 million vs C$4.1 million) reflects deliberate investment in commercial infrastructure, with sales and marketing spend more than doubling to C$3.2 million.
How filings like this one have moved
In the 30 days to Sep 17, 2026, 35.7% of the 1179 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.44%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HYFT was trading at $1.30 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $62.5M. The 52-week trading range was $0.99 to $2.99. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.